HV

Hunza Ventures

Europe, Luxembourg, Luxembourg, Luxembourg

Description

Hunza Ventures is a venture capital firm incorporated in 1998 in Luxemburg. The firm has focused its investments on early and mid-stage

Investor Profile

Hunza Ventures has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series B (25%)
  • Series A (25%)

Country Focus

  • Belgium (75%)
  • United States (25%)

Industry Focus

  • Biotechnology
  • Medical Device
  • Oncology
  • Therapeutics
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hunza Ventures frequently co-invest with?

Grifols
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Vinnof
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
LS
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 1
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Allegro Investment Fund
Europe, Vlaams-Brabant, Belgium, Heverlee
Co-Investments: 1

What are some of recent deals done by Hunza Ventures?

Celyad

Mont-saint-guibert, Brabant Wallon, Belgium

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

BiotechnologyMedical DeviceOncologyTherapeutics
Series UnknownMay 8, 2013
Amount Raised: $24,982,151
ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series AMay 3, 2012
Amount Raised: $11,830,415
Celyad

Mont-saint-guibert, Brabant Wallon, Belgium

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

BiotechnologyMedical DeviceOncologyTherapeutics
Series BJan 19, 2009
Amount Raised: $9,497,954
Formac Pharmaceuticals

Heverlee, Vlaams-Brabant, Belgium

Formac is a drug delivery company focused on the formulation of poorly soluble active pharmaceutical ingredients.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownNov 8, 2007
Amount Raised: $2,494,607